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Abstract The experimental transfer of the vanA gene
cluster from Enterococcus faecalis to Staphylococcus
aureus has raised fears about the occurrence of such
genetic transfer in clinical isolates of methicillin-resistant
staphylococci. Recently, infections by a S. aureus strain
carrying the enterococcal vancomycin resistance vanA
gene cluster were reported. The possible emergence and
dissemination of these strains is a serious health threat
and makes optimization of prevention strategies and fast
detection methods absolutely necessary. In the present
study, we developed a PCR protocol for simultaneous
detection of enterococcal vanA and vanB genes, the
staphylococcal methicillin and mupirocin resistance
markers mecA and ileS-2, and identiﬁcation of S. aureus.
As no vancomycin-resistant S. aureus isolates were
available for our study, we used mixtures of enterococcal
and staphylococcal colonies that harbored the diﬀerent
resistance markers to show that these genes could be
detected simultaneously. This protocol could be used to
facilitate the detection and identiﬁcation of predictable
S. aureus or methicillin-resistant strains carrying vanA or
vanB.
Keywords Staphylococcus aureus Æ Antibiotic
resistance Æ Glycopeptides Æ Vancomycin-resistant
S. aureus Æ Methicillin-resistant S. aureus
Introduction
Staphylococcus aureus is one of the most common causes
of nosocomial and community-acquired infections
worldwide [2, 6]. Since the emergence of methicillin-
resistant strains of S. aureus (MRSA), the glycopeptide
vancomycin has been the antibiotic of choice for serious
MRSA infections [5]. In 1996, a S. aureus strain with
intermediate resistance to vancomycin (VISA) (vanco-
mycinMIC= 8lg /ml) was ﬁrst isolated from a patient in
Japan [10]. Shortly afterward, VISA strains were isolated
in USA, Europe and other Asian countries [9, 24],
arousing considerable concern regarding the emergence
of S. aureus strains for which there will be no eﬀective
therapy. Characterization of these VISA strains indicates
that the mechanisms of resistance are complex and in-
volve changes in cell wall content and composition [3, 22].
In addition, the appearance of a powerful glycopeptide
resistance mechanism among clinical isolates of entero-
cocci, associated with the vanA and vanB gene clusters [4,
13, 15, 21], and the demonstration of experimental
transfer of the vanA gene cluster from Enterococcus fae-
calis to S. aureus [16] have raised fears about the occur-
rence of such genetic transfer in clinical isolates of
methicillin-resistant staphylococci. This type of transfer
has already been reported in clinical isolates of Strepto-
coccus bovis (vanB) [20] and Bacillus circulans (vanA) [12].
In June 2002, the world’s ﬁrst reported clinical
infection due to S. aureus with high resistance to
vancomycin (VRSA) (vancomycin MIC>128 lg/ml)
was diagnosed in a patient in the USA [23]. A second
isolate was reported in October of the same year [14].
These isolates contain the vanA genes from enterococci
and the methicillin-resistance gene mecA. The possible
emergence and dissemination of VRSA strains is a
serious health threat and makes it absolutely necessary
to optimize prevention strategies and fast detection
methods.
In the present study, we developed a multiplex PCR
protocol that allows the simultaneous detection of the
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two most widespread, transferable vancomycin resis-
tance genes, vanA and vanB, and the methicillin resis-
tance gene mecA, as well as the identiﬁcation of S.
aureus (femB). In addition, since mupirocin has been
suggested as a reasonable adjuvant agent to prevent
staphylococcal infections, and high resistance is already
widespread [5, 18, 19], detection of the ileS-2 gene was
also included.
Material and methods
Bacterial strains and DNA extraction
As there were no vancomycin-resitant S. aureus isolates available for
our study, mixtures of enterococcal and staphylococcal colonies that
harbored the diﬀerent resistance markers were used to show that
these genes could be detected simultaneously. Bacterial strains and
susceptibility testingmethods were previously described [17, 18]. The
following strains were used: E. faecalis V583 (vancomycin-resis-
tant, VanB), E. faecalis ATCC 29212 (vancomycin-susceptible),
E. faecium BM4147 (vancomycin-resistant, VanA), S. aureusATCC
29213 (methicillin- and mupirocin-susceptible), S. aureus SEIMC
(methicillin-resistant and mupirocin-susceptible), S. aureus isolate
242 (methicillin- and mupirocin-resistant) and Staphylococcus epi-
dermidis 8859-65 (methicillin- and mupirocin-resistant). For DNA
extraction, bacteria were grown overnight on BHI agar plates. One
colony from a Staphylococcus strain and one from a Enterococcus
strain were mixed and resuspended in 25 ll of sterile distilled water,
and heated at 100 C for 15 min. A 5-ll aliquot of this suspension
was directly used as template for PCR ampliﬁcation.
Simultaneous detection of vanA, vanB, femB, mecA
and ileS-2 by PCR
The primers used in this study are listed in Table 1. Multiplex PCR
assays were carried out with the DNA suspension obtained from
the Staphylococcus/Enterococcus mixtures. We ensured that our
PCR protocol was adequate for the individual ampliﬁcation of
each DNA fragment: vanB (1,145 bp), vanA (732 bp), femB
(651 bp), ileS-2 (456 bp) and mecA (310 bp) (not shown). Multi-
plex PCR was then done using the following mixtures: E. faecalis
V583 (vanB)/S. aureus 242 (femB, mecA, ileS-2), E. faecium
BM4147 (vanA)/S. aureus 242 (femB, mecA, ileS-2), E. faecalis
ATCC 29212/S. aureus ATCC 29213 (femB), E. faecalis V583
(vanB)/S. aureus ATCC 29213 (femB), E. faecium BM4147 (vanA)/
S. aureus ATCC 29213 (femB), E. faecalis V583 (vanB)/S. aureus
SEIMC (femB, mecA), E. faecium BM4147 (vanA)/S. aureus SEI-
MC (femB, mecA), E. faecalis V583 (vanB)/S. epidermidis (mecA,
ileS-2), E. faecium BM4147 (vanA)/S. epidermidis (mecA, ileS-2).
The PCR conditions used were modiﬁcations of protocols previ-
ously described by us [17, 18]. A 5-ll aliquot of the DNA
suspension was added to 28.5 ll of PCR mixture consisting of 1·
reaction buﬀer [16 mM (NH4)2SO4, 67 mM Tris-HCl (pH 8.8)],
0.2 mM concentration of each of the four dNTPs (Promega Corp.,
Madison, Wis.), 3 mM MgCl2, 1.5 lM of each femB primer,
0.5 lM of each vanA and vanB primer, 0.4 lM of each ileS-2 pri-
mer and 0.4 lM of each mecA primer, and 1.25 U of Taq DNA
polymerase (Bioline, London, UK). The femB primers were used to
identify S. aureus strains, and the mecA, ileS-2, vanA and vanB
primers to detect the respective resistance markers. In order to
reduce the formation of nonspeciﬁc extension products, the pro-
tocol included a ‘‘hot-start’’. DNA ampliﬁcation was carried out in
a GeneAmp PCR system 2700 (Applied Biosystems, Foster City,
Calif., USA) with the following thermal cycling proﬁle: an initial
denaturation step at 94 C for 5 min was followed by 10 cycles of
ampliﬁcation (denaturation at 94 C for 30 s, annealing at 64 C
for 30 s, and extension at 72 C for 45 s), and another 25 cycles of
ampliﬁcation (denaturation at 94 C for 30 s, annealing at 50 C
for 45 s, and extension at 72 C for 2 min), ending with a ﬁnal
extension step at 72 C for 10 min. After PCR ampliﬁcation, 5 ll
were removed and subjected to agarose gel electrophoresis (2%
agarose, 1· TBE, 100 V) to estimate the sizes of the ampliﬁcation
products by comparison with a 100-bp DNA ladder (Roche
Diagnostics, Mannheim, Germany). The gel was stained with
ethidium bromide and the amplicons were visualized under a UV
light.
Results and discussion
The reaction conditions for the multiplex PCR assay were
optimized to ensure that each target sequence was satis-
factorily ampliﬁed. The primers used in this study diﬀer in
annealing temperatures, which increased the possibility of
occurrence of unwanted bands that originated from
nonspeciﬁc ampliﬁcation. Therefore, two rounds of
ampliﬁcation with diﬀerent annealing temperatures were
carried out.Multiplex PCRwith targets that diﬀer widely
in size often favors ampliﬁcation of the shorter target over
the longer ones [18]. Thus, to ensure ampliﬁcation of each
target, diﬀerent primer concentrations, template DNA
preparations, and MgCl2 concentrations were assayed,
and those described above were chosen.
Figure 1 shows the results obtained with the opti-
mized multiplex PCR assay as described in Material and
methods; ampliﬁcation of vanA, vanB, femB, ileS-2 and
mecA targets produced distinct bands corresponding to
their respective molecular size that were easily recog-
nizable. vanA or vanB could be detected in mixtures
containing femB (lanes 4 and 5), femB and mecA (lanes 6
and 7), and femB, mecA, and ileS-2 (lanes 1 and 2).
Table 1 PCR primers used in this study
Primer pair Target gene 5¢–3¢ Sequence Product length (bp) Reference
VanBfor
VanBrev
vanB GTGCTGCGAGATACCACAGA 1,145 This study
CGAACACCATGCAACATTTC
VanA1
VanA2
vanA GGGAAAACGACAATTGC 732 [7]
GTACAATGCGGCCGTTA
FemB1
FemB2
femB TTACAGAGTTAACTGTTACC 651 [11]
ATACAAATCCAGCACGCTCT
MupA
MupB
ileS-2 TATATTATGCGATGGAAGGTTGG 456 [1]
AATAAAATCAGCTGGAAAGTGTTG
MecA1
MecA2
mecA GTAGAAATGACTGAACGTCCGATAA 310 [8]
CCAATTCCACATTGTTTCGGTCTAA
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vanA, vanB, ileS-2 and mecA were also simultaneously
detected in the presence of the S. epidermidis (femB–)
DNA. No ampliﬁcation of the antibiotic resistance
markers was observed in the control without DNA (lane
10) or in the mixture containing two susceptible strains
(E. faecalis ATCC 29212 and S. aureus ATCC 29213)
(lane 3). The entire protocol for the multiplex PCR as-
say, including the DNA extraction and electrophoresis,
can be completed in less than 5 h.
Since vancomycin is frequently the drug of choice for
the treatment of infections caused by now common
MRSA, the recent appearance of a fully vancomycin-
resistant strain of S. aureus has confronted us with the
possible existence of non-tractable infections. The pro-
tocol described here could be used to facilitate the
detection and identiﬁcation of S. aureus or MRSA
strains carrying vanA or vanB.
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Fig. 1 Agarose gel electrophoresis of multiplex PCR ampliﬁcation
products from diﬀerent enterococcal/staphylococcal mixes. Lanes:
M 100-bp DNA ladder (Roche Diagnostics, Mannheim, Ger-
many), 1 Enterococcus faecalis V583 (vanB1)/Staphylococcus aureus
242 (femB, mecA, ileS-2), 2 Enterococcus faecium BM4147 (vanA)/
S. aureus 242 (femB, mecA, ileS-2), 3 E. faecalis ATCC 29212/S.
aureus ATCC 29213 (femB), 4 E. faecalis V583 (vanB1)/S. aureus
ATCC 29213 (femB), 5 E. faecium BM4147 (vanA)/S. aureus ATCC
29213 (femB), 6 E. faecalis V583 (vanB1)/S. aureus SEIMC (femB,
mecA), 7 E. faecium BM4147 (vanA)/S. aureus SEIMC (femB,
mecA), 8 E. faecalis V583 (vanB1)/S. epidermidis (mecA, ileS-2), 9
E. faecium BM4147 (vanA)/S. epidermidis (mecA, ileS-2), 10 control
without a DNA template
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